CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.92%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
516
New
Increased
Reduced
Closed

Top Buys

1 +$7.38M
2 +$5.53M
3 +$4.72M
4
AVGO icon
Broadcom
AVGO
+$3.5M
5
FUTU icon
Futu Holdings
FUTU
+$3.44M

Top Sells

1 +$2.29M
2 +$2.16M
3 +$2.13M
4
ABT icon
Abbott
ABT
+$2.09M
5
TSM icon
TSMC
TSM
+$2.07M

Sector Composition

1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INBX icon
401
Inhibrx
INBX
$1.11B
$85.5K 0.01%
2,539
-368
RGNX icon
402
Regenxbio
RGNX
$565M
$85.4K 0.01%
8,854
-1,221
SLDB icon
403
Solid Biosciences
SLDB
$503M
$84.2K 0.01%
13,649
-1,920
CYD icon
404
China Yuchai International
CYD
$1.7B
$82.7K 0.01%
+2,000
ABSI icon
405
Absci
ABSI
$450M
$79.7K 0.01%
26,209
+589
PHVS icon
406
Pharvaris
PHVS
$1.76B
$74.8K 0.01%
+3,000
MRVI icon
407
Maravai LifeSciences
MRVI
$487M
$72.8K 0.01%
25,360
-3,557
ATEC icon
408
Alphatec Holdings
ATEC
$2.2B
$72.7K 0.01%
+5,000
ATXS
409
DELISTED
Astria Therapeutics
ATXS
$72K 0.01%
9,892
-1,443
FDMT icon
410
4D Molecular Therapeutics
FDMT
$452M
$71.1K 0.01%
8,186
-1,118
EOLS icon
411
Evolus
EOLS
$304M
$69.6K 0.01%
11,338
-1,612
ALMS
412
Alumis Inc
ALMS
$3.06B
$67.8K 0.01%
16,982
-2,215
PACB icon
413
Pacific Biosciences
PACB
$682M
$67.4K 0.01%
52,650
-9,540
AURA icon
414
Aura Biosciences
AURA
$356M
$67.3K 0.01%
10,889
-1,564
LXEO icon
415
Lexeo Therapeutics
LXEO
$541M
$62.9K 0.01%
9,466
+2,799
BCYC
416
Bicycle Therapeutics
BCYC
$445M
$62.7K 0.01%
8,104
-762
RCKT icon
417
Rocket Pharmaceuticals
RCKT
$377M
$61.7K 0.01%
18,914
-2,725
CGEM icon
418
Cullinan Oncology
CGEM
$707M
$61.4K 0.01%
10,355
-1,498
ALT icon
419
Altimmune
ALT
$632M
$58.3K ﹤0.01%
15,470
-820
TKNO icon
420
Alpha Teknova
TKNO
$130M
$58.1K ﹤0.01%
9,380
-1,353
BBOT
421
BridgeBio Oncology
BBOT
$937M
$57.9K ﹤0.01%
+5,000
AMRN
422
Amarin Corp
AMRN
$310M
$57.9K ﹤0.01%
3,534
-487
REPL icon
423
Replimune Group
REPL
$551M
$57.3K ﹤0.01%
13,682
-1,801
AUTL
424
Autolus Therapeutics
AUTL
$365M
$57.3K ﹤0.01%
35,157
-5,116
EDIT icon
425
Editas Medicine
EDIT
$194M
$54.7K ﹤0.01%
15,762
-1,051